• A reversal of the federal ban on the use of controversial pesticides linked to potential health disorders illustrates a pressing need for MustGrow’s patented technology for natural biopesticide solutions
• MustGrow’s research and development program focuses on a portfolio of natural biopesticides and biofertilizers, and it is expanding into the cannabis and tobacco industries
• Global crop protection is a multibillion-dollar market that’s expected to surge over the next five years

The Environmental Protection Agency’s recent decision to allow the use of two chemical pesticides – chlorpyrifos and sulfoxaflor, both made by Corteva Agriscience, formerly part of DowDuPont – highlights the importance of research into safe, natural biopesticides such as those now under development by MustGrow Biologics Corp. (CSE: MGRO).

Numerous organizations are pushing to ban the pesticides as harmful substances to humans and other living creatures. According to Reuters, studies show that exposure to chlorpyrifos is linked to low birth weight, reduced IQ, attention disorders and other issues in infants and children (http://ibn.fm/RvwlO). Likewise, The Associated Press reports that the use of sulfoxaflor is decimating beneficial insects such as the honeybee (http://ibn.fm/hQVwQ).

Agricultural biotech company MustGrow Biologics is developing and commercializing a portfolio of natural biopesticides and biofertilizers that may provide high quality, organic pest control to growers facing soil-borne diseases and pests that ruin crops, including those in the cannabis and tobacco industries. MustGrow’s patented products are refined from compounds of the mustard plant, utilizing the plant’s natural defense mechanism as a pre-plant soil biopesticide treatment (http://ibn.fm/RhJAF).

MustGrow’s signature products are shown to deliver effective pathogen and pest control to ensure plant growth and high yields in a variety of agricultural settings (http://ibn.fm/7JqnU). MustGrow is also testing the potential application of its technology in the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020, and for nematode biocontrol in the global tobacco industry.

Previous research findings made in collaboration with Virginia Tech’s Southern Piedmont Agricultural Research and Extension Center on the safety and efficacy of MustGrow’s patented granular organic biopesticide as a natural pre-plant soil treatment are encouraging, leading to a new research program, according to a news release (http://ibn.fm/GIIq6). The R&D effort targets tobacco cyst nematodes, a parasitic ringworm that has been reported in 11 tobacco-producing countries on four continents.

Based on MustGrow’s promising scientific achievements and research, advance corporate collaboration discussions are now underway with tobacco industry leaders. The recent appointment of Altria Group veteran Brian Quigley to MustGrow’s board of directors illustrates the company’s belief that there is significant opportunity to seek approval of MustGrow’s second generation liquid technology as an organic biopesticide for eventual use by tobacco growers (http://ibn.fm/Ymlqh).

For more information, visit the company’s website at www.MustGrow.ca

NOTE TO INVESTORS: The latest news and updates relating to MGRO are available in the company’s newsroom at http://ibn.fm/MGRO

• Grapefruit has entered into a letter of intent with Dogwood Management Group Inc. to acquire and manage retail dispensaries in Northern and Southern California
• The company recently commenced retail sales of its first Grapefruit brand of cannabis-infused edible gummies under the trade name Sugar Stoned®
• Grapefruit is preparing to introduce more cannabis-infused offerings, including its new wellness and lifestyle brands line of CBD and THC mixed vaporizer cartridges, in Q3 2019
• Parent company Imaging3 Inc. plans to change its ticker symbol and corporate name in order to better reflect Grapefruit’s branding across its platforms

Grapefruit Boulevard Investments Inc., a California corporation and a wholly owned subsidiary of Imaging3 Inc. (OTCQB: IGNG), has entered into a letter of intent with Dogwood Management Group Inc. The nonbinding letter of intent outlines the agreement between the two companies: Grapefruit plans to acquire and Dogwood will manage California-licensed and fully compliant retail cannabis dispensaries throughout California that meet the regulatory, operational and financial results requirements for the two companies (http://ibn.fm/KTW7P).

“We continue to press purposefully forward toward our ultimate goal of vertical integration by implementing this initial program to build a network of fully compliant, legal dispensaries by entering into this arrangement with Dogwood which eliminates the necessity of building an in house acquisition staff and dispensary management team and thereby significantly accelerates our legal retail dispensary acquisition program,” Grapefruit CEO Bradley Yourist stated in a news release. “Dogwood’s CEO Steely Inoue and I, and our respective management teams, will work closely together over the coming months to identify, acquire and successfully manage various retail cannabis dispensaries in both Northern and Southern California. It has always been Grapefruit’s intent to become a fully vertically integrated, seed to sale cannabis and CBD company, and our new relationship with Dogwood Management advances that goal.”

Yourist described CEO Steely Inoue and his Dogwood management team as “true cannabis professionals” bringing a “complete turnkey retail dispensary management program” to Grapefruit. He praised Dogwood’s extensive experience in managing some of the highest-profile, most profitable dispensaries in California, which is home to one of the most competitive cannabis markets in the world.

Yourist concluded, “With this new collaboration between Dogwood and Grapefruit, we have set the stage for Grapefruit to quickly acquire legal, compliant and auditable retail locations in California to rapidly expand Grapefruit’s revenues.”

Grapefruit is poised to expand its laboratory extraction operations and distribution services throughout California. In June, the company commenced retail sales of its first brand of cannabis-infused edible gummies in the state under trade name Sugar Stoned (http://ibn.fm/GLSWc).

“Retail cannabis product consumers will be able to enjoy our Sugar Stoned infused gummies with the knowledge that Grapefruit products have been tested and are certified to be pesticide and heavy metal free by a third-party laboratory before being released at retail,” Yourist added (http://ibn.fm/cITZT).

Based in Westwood, California, Grapefruit is a manufacturer and distributor of various cannabis products and holds both a manufacturing and distribution license issued by the State of California.

For more information, visit the company’s website at www.GrapefruitBlvd.com

NOTE TO INVESTORS: The latest news and updates relating to IGNG are available in the company’s newsroom at http://ibn.fm/IGNG

• PLUS Uplift and Restore products ranked as the two best-selling cannabis edibles in California in terms of both dollars and units sold
• Plus Products has expanded into Nevada through a definitive agreement with TapRoot Holdings Inc.
• Projections estimate that Nevada will surpass $700 million in cannabis sales by 2020

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), a manufacturer and marketer of cannabis food products, is committed to ensuring the consistency of its products as it expands and sees continued success in the industry. PLUS co-founder and CEO Jake Heimark recently reiterated the company’s commitment to maintaining quality and consistency in PLUS products, wherever they are sold (http://ibn.fm/3xaUk).

BDS Analytics reported that, in Q1 2019 (the three months ended March 31), PLUS Uplift and PLUS Restore gummies were the two best-selling edible products in California in terms of both dollars and units sold (http://ibn.fm/xYXtH). PLUS Uplift brand owned 25 percent market share YTD in 2019, the company reported.

Building on its success in selling edible products in California, Plus Products has now entered Nevada, marking its first expansion outside California. The company is making this move through a definitive agreement with TapRoot Holdings Inc., a vertically integrated cannabis company operating cultivation and manufacturing facilities in Las Vegas.

“As we look to expand beyond California, we remain committed to producing a consistent product in all jurisdictions,” Heimark stated in a news release. “We want the PLUS customer to have the same experience with our products whether they buy it in LA or in Las Vegas.” The company will begin marketing its gummies and low-dose mints in Nevada dispensaries this summer.

An analysis article (http://ibn.fm/VdB6z) by Technical420 author Anthony Varrell calls the entry by Plus Products into Nevada a “growth driver” and deems Las Vegas a “key market to building an internationally recognized brand.” He cited the 45 million visitors to Las Vegas each year as an important factor in the move. Varrell also noted that Plus Products will be the manufacturing operations partner as it expands into new markets, ensuring quality and consistency. The article also included research by Arcview Market Research, combined with BDS Analytics, that projects retail sales of cannabis in Nevada to surpass $700 million by 2020.

San Mateo, California-based PLUS is a cannabis-infused, branded products manufacturer selling to regulated medicinal and adult-use recreational markets in California and Nevada. PLUS is focused on building the largest cannabis brand by growing organically and through acquisitions.

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

• Cannabis users have historically preferred to inhale smoke from the burned plant in order to achieve rapid-onset absorption of its properties, but Lexaria Bioscience is making it possible to achieve similar results through oral ingestion
• Lexaria’s revolutionary DehydraTECH technology allows cannabis users to eliminate the unhealthy effects of smoking from their routines, and the product is being tested with nicotine as well
• Cannabis-infused edibles sales are expected to climb from about $1 billion currently to about $4.1 billion by 2022

Consumable bioactive product innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) will expand the reach of its revolutionary DehydraTECH technology across the United States courtesy of a definitive five-year agreement that allows B2B hemp substance manufacturing firm Universal Hemp LLC to include it in many cannabidiol (CBD)-based food ingredients.

Lexaria’s DehydraTECH is an ingested drug delivery platform patented to work with all psychoactive and non-psychoactive cannabinoids (http://ibn.fm/qPDtt), making them bioavailable through absorption at a rate comparable to the rapid-onset effect of inhaled cannabis without the detrimental health effects that arise from smoking. The Lexaria technology accomplishes this by speeding the rate of absorption for chemicals in edibles – an otherwise slow means of making substances bioavailable through the bloodstream.

DehydraTECH also allows the substances to be ingested without the need for the unhealthy sweeteners that are commonly used in cannabis-infused products to mask bitter tastes, according to the company.

The Universal Hemp agreement packages DehydraTECH with food ingredients to be produced for the nutraceutical and consumer packaged goods industries. In addition to the United States, outlets in Canada will be included once that country’s regulations allow edible cannabis products.

“In terms of bioavailability, shelf stability and taste this is the best performing technology in the market, hands down. Our corporate customers cannot wait to put our water-soluble solution into their products!” Universal Hemp CEO and Founder Chad Kahunahana stated in a news release about the agreement (http://ibn.fm/SaAP7).

Chris Bunka, CEO of Lexaria Bioscience, noted that the agreement’s new inroads to the hemp industry will not only deliver rapid product uptake, but also allow the company to deliver precision dosing and maximum product strength. Cannabis industry publication Green Entrepreneur reported that cannabis-infused edibles sales reached over $1 billion in 2018 and are expected to amount to about $4.1 billion by 2022 (http://ibn.fm/Ew9jX), showing an exponential level of growth.

In addition, Lexaria also recently announced its entry into a CBD beverage license agreement with Nic’s Beverages LLC for use in CBD-based beverages to be produced and sold throughout the United States. Nic’s Beverages will initially produce ready-to-drink (RTD) cold brew coffees enhanced with CBD from multi-spectrum hemp oil (http://ibn.fm/HvuxQ).

Lexaria is the only company in the world to have a patent issued for the oral delivery of all cannabinoids. DehydraTECH has received 11 patents in the United States and Australia, and it has about 60 additional patents pending in more than 40 countries worldwide. The DehydraTECH platform has also been used in research on nicotine absorption (http://ibn.fm/0D8wB).

The company’s informative July 11 investor conference video on Virtual Investor Conferences’ series site is now accessible online, as noted in a news release (http://ibn.fm/ysLBZ).

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

• Plus Products is benefiting from new opportunities to expand its consumer base through the microdosing movement
• The company is moving toward establishing itself as a leading brand in the international market
• PLUS is exploring a rare opportunity to simultaneously improve quality control, cut costs and grow revenues through possible acquisition

Cannabis-infused products manufacturer Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) is creating edibles to support a health and active lifestyle for both new and veteran consumers. Drawing from more than 40 years of experience in food manufacturing, the company makes edibles from scratch using only the highest-quality extracts and kosher ingredients to create a consistent and delicious cannabis experience. To do this well requires foresight and the collaboration of a well-orchestrated team of experts across multiple fields. The PLUS team includes Michelin-star chefs, Ivy League chemists, food manufacturing experts, engineers, machinists, visionaries, creatives and strategists.

Seeking to strengthen its position, Plus Products moved to the largest cannabis market in the world — California — in 2015. From its 12,000-square-foot, food-safe, cannabis manufacturing facility in Adelanto, California, PLUS has set itself apart from the competition. In Q3 2018, PLUS(TM) was ranked the top edibles brand in California (http://ibn.fm/qDLju).

PLUS products are available in more than 200 licensed dispensaries and through delivery services across the state. The company is focused on building the largest cannabis brand through organic and acquisitional growth. In June, PLUS uplisted to the OTCQX Best Market.

Plus Products is continually looking toward new opportunities to expand its consumer base. This attention to rising opportunities is evident in a recent launch of a new product line that provides consumers with microdosing options (http://ibn.fm/Wzwis). The company’s commitment to quality and consistency builds trust with consumers who know what to expect from every PLUS gummy and mint.

The new microdosing mints provide consumers with the same exceptional culinary commitment, unique flavors and controlled dosage as the gummies. In addition, the microdosing option allows consumers to add cannabis into their healthy lifestyles at a lower dose, making PLUS even more approachable and convenient. PLUS Classic Mints, which are packaged in a child-resistant tin, provide 2.5 mg THC with less than 0.1 mg CBD.

Along with the release of its microdosing mints, PLUS expanded into the Nevada cannabis market through a definitive partnership agreement with TapRoot Holdings Inc. Both the gummies and the mints are now available in Nevada dispensaries. The company sees this new venture as a key component to building an internationally recognized brand. Nevada, a state that sees 45 million visitors a year from all over the world, is anticipated to surpass $700 million in cannabis retail sales in 2020 (http://ibn.fm/fUlOx).

In addition, PLUS is currently exploring a purchased option to buy Emerald Bay Wellness LLC and the business assets of Emerald Bay Extracts. The option grants Plus Products the right to buy, but not the obligation, as the company explores the acquisition. Emerald Bay is one of PLUS’ largest suppliers of cannabis oil.

If the company moves forward with the purchase, the strategic move is expected to provide PLUS with in-house cannabis extraction capabilities that would improve quality control, increase gross margin and create a new revenue stream and product-development capabilities (http://ibn.fm/lke79). PLUS co-founder and CEO Jake Heimark pointed out that the acquisition would provide the company with direct interaction with the cannabis plant and the ability to explore the many benefits associated with the crop.

Emerald Bay’s professionalism and expertise regarding rapid scalability has the potential to flourish under the umbrella of PLUS’ resources. “Ultimately, this is a rare opportunity to improve quality control, cut costs and grow revenues all at the same time,” Heimark stated in a news release.

As PLUS looks to the future, one thing is certain: the company is committed to making cannabis safe and approachable for all types of consumers by providing consistent, dosable, delicious products that stand out from the competition.

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

• ETST stock recently caught the attention of InvestorPlace analyst Mark Putrino
• Putrino noted in an article that ETST stock stands out, because the company’s management team and advisory board exhibit impressive business experience
• ETST was listed in the InvestorPlace article as “one of seven potential stocks to buy”

Earth Science Tech Inc. (OTCQB: ETST) was named in an InvestorPlace article by Mark Putrino as one of ‘7 Marijuana Penny Stocks I May Buy’, in large part because of the extensive business and industry experience of ETST’s executive team and advisory board (http://ibn.fm/q1CXa).

ETST is a biotech company focused on the nutraceutical and pharmaceutical fields. The company markets a line of cannabis products, has a portfolio of diverse subsidiaries and performs research and development in the cannabis and industrial hemp space.

The InvestorPlace article specifically cites the more than 30 years of business experience with large New York-based corporations that ETST CFO Wendell Hecker brings to the table. It also notes the impressive experience of COO Gagan Hunter and several advisory board members. Hunter, an industry and community educator, has more than 20 years of experience as a teacher of nutrition, vitamins, herbs and supplements. He also has an extensive background in sales, marketing and management.

“The following seven companies seem to have weathered the storm over the past year,” Putrino wrote in the InvestorPlace article. “This could be an indication that they may have favorable prospects for the future. If they survive the bad times, maybe they will prosper in the good times. Because of this, they are on my radar screen as potential buys.”

In addition to ETST, Putrino listed 48North Cannabis Corp. (TSX.V: NRTH), Two Rivers Water and Farming (OTCQB: TURV), National Access Cannabis Corp. (OTC: NACNF), Pivot Pharmaceuticals Inc. (OTCQB: PVOTF), Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) and Halo Labs (OTCQX: AGEEF).

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST

• VPR Brands continues to invest in inventory and new products in an effort to keep up with increased demand and promote year-over-year gains
• The company recently updated its best-selling battery, ELF
• VPRB is expanding exposure to thousands of stores, increasing convenience and approachability for retailers

Innovative technology holding company VPR Brands LP (OTC: VPRB) is making a name for itself in the vaping market through product development and partnerships with top international brands. VPRB is focused on offering high-performance, high-quality products that bring value to partners, consumers and investors.

Through the leadership of its experienced management team, VPRB has pivoted toward cannabis products, a move that has increased sales and profit margins. In its Q4 2019 financials (http://ibn.fm/Ktbun), the company reported an increase in quarterly revenues of approximately 31 percent year-over-year.

VPRB CEO Kevin Frija stated that the company will remain focused on sustainable, manageable growth and “continue to invest in inventory and new products to be able to keep up with the increased demand.”

The company recently announced an update on its strategy to increase the visibility of its lifestyle brand, HoneyStick (http://ibn.fm/5lkwi). The combination of high tech, high performance, dependability and affordability makes HoneyStick stand out from other upper-tier vaporizers. Holding true to these principles, the company has increased the reliability of the brand through the new and improved ELF Variable Voltage Mini Vape Mod.

In 2018, ELF proved to be the company’s best-selling battery, with more than 73,000 units sold. The company chose to upgrade the customer favorite to further increase satisfaction. The newest feature of ELF allows the user to adjust between 2.5 and 4 volts, providing customization, smoother pulls and bigger rips. The HoneyStick Elf is an auto-draw conceal oil vaporizer kit that comes with a high-performance glass cartridge, a ceramic heater and a mouthpiece that is compact and stylish.

JUUL authorized distributor and Chicagoland’s premier vape and smoke shop distributor, HS Wholesale, is now selling the HoneyStick brand (http://ibn.fm/BSnY5). Items available through HS Wholesale include the Honey Stick Bee Keeper Kit, HoneyStick ELF, HoneyStick Rip & Ditch Dab disposable, HoneyStick Bee-Master Oil Vape Kit, BeeBox 510-thread Auto Draw Vape Concealer and HoneyStick MiniMax PRO Push Button Flip Key FOB Vaporizer. This new venture is part of a strategic plan aimed at adding distribution partners in order to reach a larger stateside market and continue movement forward in an international sales effort that is building relationships with distributors worldwide.

“In the last few years, HS Wholesale has really become a major supplier in vape and smoke distribution, especially of premium liquids and equipment,” VPRB COO Dan Hoff noted in a news release. “This new dropship program expands our exposure to thousands of stores and allows retailers to bring in the HoneyStick brand while placing their regular fulfillment order through HS Wholesale.”

For more information, visit the company’s website at www.VPRBrands.com

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at http://ibn.fm/VPRB

• In March 2019, DVLP reported an 800 percent year-over-year increase in monthly revenue
• DVLP’s growth strategy includes key acquisitions, such as that of Infusionz LLC, a manufacturer of CBD products
• DVLP’s Form 10 Registration Statement, filed with the SEC, became effective July 1

Golden Developing Solutions Inc. (OTC: DVLP) is showing exponential growth with its multitiered strategy working in the CBD, hemp and cannabis spaces. The strategy includes a diverse focus on online product sales, acquisitions, manufacturing, product branding and plans for the development of a 25,000-square-foot production facility in Denver, Colorado (http://ibn.fm/k7ulC).

DVLP has developed a multifaceted strategy to become a top competitor in the industry. Its plan synthesizes key acquisitions, diverse brands and products, and an increase in production capability in order to meet the growing industry demand for quality cannabis products that has yet to be met.

This strategy also led to the company’s recent acquisition of Infusionz LLC. “Our CBD Infusionz segment is bursting at the seams right now,” DVLP CEO Stavros Triant stated in a news release (http://ibn.fm/BHTw9). “Demand already vastly outstrips supply capacity. This new facility directly addresses that issue and should provide the necessary room for the explosive growth that we anticipated when we made that acquisition in March.”

Another important milestone for DVLP was reaching fully reporting status with the SEC, effective July 1. “This… has been groundbreaking for our company, as we’re finally able to announce that our Form 10 Registration Statement is effective,” Triant noted in a release. “We’re now a fully reporting company to the SEC.” DVLP’s Form 10 registration statement ensures continued transparency with current and future potential investors (http://ibn.fm/3aILS).

The company is developing a 25,000-square-foot facility in Denver, Colorado, which will serve as the primary production base for Infusionz LLC. DVLP finalized a 54-month, initial-term lease for the facility, and move in has begun, with full-scale production expected within weeks. DVLP projects a significant increase in production capacity once the facility is up and running.

The effectiveness of DVLP’s diverse strategy is evident. From March 2018 to March 2019, Golden Developing Solutions saw an 800 percent jump in performance, with additional growth announced in May (http://ibn.fm/bZMF5). “We are seeing tremendous validation on a strategic level,” added Triant. “The move to expand our exposure to the CBD space was very well-timed and is already beginning to pay off. The numbers for March bear that out unmistakably.”

For more information, visit the company’s website at www.GoldenDeveloping.com

NOTE TO INVESTORS: The latest news and updates relating to DVLP are available in the company’s newsroom at http://ibn.fm/DVLP

• SinglePoint focuses on acquisitions of undervalued, cash-flow positive, high-potential companies
• SinglePoint recently closed an acquisition of Direct Solar of America
• The company’s diverse portfolio covers a wide range of sectors

SinglePoint Inc. (OTCQB: SING) is on a mission to seize opportunities via an aggressive expansion strategy across a broad range of assets. Headquartered in Phoenix, Arizona, the company specializes in acquisitions of small to mid-sized firms, with a focus on new technologies, including payment processing, industrial hemp and renewable energy solutions.

Established in 2007, SinglePoint works with key company management personnel to develop successful candidate acquisition targets. These target companies are undervalued and cash-flow positive, with high potential and verified assets. SinglePoint becomes active within the acquired businesses to influence strategy and direction for sustained growth.

SinglePoint’s portfolio includes mobile payments, ancillary cannabis services and renewable energy solutions. The company’s strategic acquisitions give it a strong presence in the multibillion-dollar legalized cannabis market. An article published by Forbes (http://ibn.fm/5Zdh3) reads, “According to Arcview Market Research and its research partner BDS Analytics, over the next 10 years, the legal cannabis industry will see much progress around the globe. Spending on legal cannabis worldwide is expected to hit $57 billion by 2027.”

Recently, an exclusive interview with SinglePoint CEO Greg Lambrecht aired on the RedChip Money Report (http://ibn.fm/wAQyY). Lambrecht discussed the company’s rapidly expanding solar business segment (http://ibn.fm/q8MqJ). Of note in the interview is Lambrecht’s overview of SinglePoint’s recent closing on the acquisition of Direct Solar of America.

In 2018, Direct Solar eclipsed just over $1 million in sales, and the company has seen tremendous growth over the past year, putting it on a run rate for over $5 million in 2019, which aligns well with the industry overall. In Q4 2018, the U.S. solar market installed 4.2 GWdc of solar PV, marking a 139 percent increase from Q3 2018 and a 4 percent increase from Q4 2017. Much of this growth is attributed to environmental awareness and the overall cost of solar becoming more affordable (http://ibn.fm/XAs2S).

Moreover, by way of SingleSeed, one of its wholly owned subsidiaries, SinglePoint is providing products and services to the cannabis sector. SinglePoint is also looking to advance its cannabis initiatives in other ways. “Industrial-derived hemp has created a wave of new products and opportunities in which SinglePoint has been able to drive additional revenue and profit,” SinglePoint President Wil Ralston stated in a news release.

In addition, SinglePoint’s payment-processing offering is a one-stop shop for businesses’ payment-acceptance needs. Furthermore, SinglePoint simplifies mobile messaging by enabling companies to send text messages seamlessly to all mobile subscribers simultaneously. Businesses can easily send notifications, deals, coupons and even requests for payment.

SinglePoint continues to take advantage of technology expertise and emerging opportunities in the cannabis and blockchain markets. The company offers investors the opportunity to make investments across a broad array of assets for investor portfolio diversification. SinglePoint is building its own portfolio by acquiring an interest in undervalued subsidiaries, providing investors with a rich, diversified holding base.

For more information, visit the company’s website at www.SinglePoint.com

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

• As the legal marijuana industry continues to rapidly expand, regulatory bodies in the U.S. and other parts of the world are facing lobby pressure to ensure widespread adoption
• Companies like Lexaria Bioscience have opposed such developments to ensure responsible and safe introduction of legal cannabis products for medicinal and recreational use
• Current Lexaria corporate policies go beyond the legislative framework to deliver sensitive products to people in need while also protecting vulnerable community members

The multi-million-dollar cannabis industry is growing rapidly. In the U.S. and other parts of the world, there has been a push for legislative changes and the creation of a liberal legalization framework. While many are eager for the adoption to become full scale, companies like Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) campaign for responsibility and a health-focused approach.

Across the U.S., members of the cannabis industry and lobbyists have been trying to reach Congress in order to secure approval for legal marijuana, a recent Fox News report suggests (http://ibn.fm/k0JsO). Until recently, Republicans seemed to be in stark opposition of such a move. Eventually, the political climate changed, especially after former House Speaker John Boehner became a lead promoter of marijuana legalization.

The industry has been growing steadily over the past few years. As of today, 10 U.S. states have legalized recreational marijuana use and 33 have granted approval for medicinal purposes. In 2017, the economic impact of the legal marijuana industry exceeded $20 billion (http://ibn.fm/MTADG). Cannabis employs five times as many people in America as the coal industry, and investors spent over $10 billion on the sector in 2018.

By 2023, U.S. retail marijuana sales are anticipated to go beyond $30 billion (http://ibn.fm/TUbcO). Recreational marijuana sales will continue growing exponentially, driving the overall expansion of the sector.

Through legal amendments, the U.S. is expected to fast-track marijuana legalization across all states. Some of the stimuli that may be used to ensure the quick change of the legislative framework include providing access to the federal banking system for commercial marijuana and limited FDA ability to enforce current drug laws, Fox News reported.

Research suggests that legalization is not necessarily curbing black market activities. In fact, legalized states have flourishing black markets.

Furthermore, doctors and psychologists have continuously raised awareness about research suggesting that regular marijuana use, especially among those aged 25 and younger, could contribute to psychological issues like depression and may alter normal development processes in the young human brain. To ensure a balanced approach toward cannabis legalization, companies like Lexaria Bioscience have announced their responsible marijuana policies.

Biotechnology company and drug delivery platform innovator Lexaria’s philosophy focuses on recognizing the potential for harm within sensitive industries. Thus, Lexaria has set up its own corporate policies that go beyond legal restrictions and recommendations.

As per the current Lexaria corporate policy, the company does not support the sale of medical cannabis containing more than 0.3 percent THC to any medical marijuana patient under the age of 21 (unless special approval is obtained from the relevant governmental agency).

“Our goal is to safely help people live healthy and productive lives,” Lexaria Bioscience CEO Chris Bunka said in a news release. Lexaria’s policies are a major step in the right direction, because they ensure the provision of health benefits to members of the community, he concluded.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP